Napodano, Cecilia
 Distribuzione geografica
Continente #
NA - Nord America 1.292
EU - Europa 999
AS - Asia 409
OC - Oceania 12
SA - Sud America 11
AF - Africa 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.730
Nazione #
US - Stati Uniti d'America 1.281
SE - Svezia 397
IT - Italia 198
SG - Singapore 150
CN - Cina 143
IE - Irlanda 97
DE - Germania 86
ID - Indonesia 49
FR - Francia 45
RU - Federazione Russa 42
GB - Regno Unito 37
FI - Finlandia 27
IN - India 24
BE - Belgio 17
UA - Ucraina 10
CA - Canada 9
CZ - Repubblica Ceca 9
HK - Hong Kong 9
BR - Brasile 7
IR - Iran 7
AU - Australia 6
CI - Costa d'Avorio 6
ES - Italia 6
JP - Giappone 6
NZ - Nuova Zelanda 6
BY - Bielorussia 4
DK - Danimarca 4
KR - Corea 4
NL - Olanda 4
TR - Turchia 4
CH - Svizzera 3
KZ - Kazakistan 3
LT - Lituania 3
CL - Cile 2
GR - Grecia 2
HU - Ungheria 2
MX - Messico 2
PH - Filippine 2
PT - Portogallo 2
RO - Romania 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
AT - Austria 1
BG - Bulgaria 1
CY - Cipro 1
EU - Europa 1
KH - Cambogia 1
MM - Myanmar 1
MY - Malesia 1
NP - Nepal 1
PY - Paraguay 1
Totale 2.730
Città #
Chandler 383
Ashburn 128
Singapore 128
Dublin 97
New York 74
Jakarta 49
San Mateo 49
Rome 48
Princeton 35
Moscow 33
Marseille 32
Boston 30
Wilmington 30
Helsinki 23
Fairfield 22
Beijing 20
Cattolica 20
Nanjing 19
Milan 17
Munich 15
Redwood City 15
Bologna 14
Bremen 14
Brussels 14
Castelnuovo di Val di Cecina 14
Dearborn 14
Falls Church 14
Boardman 13
Chicago 13
Norwalk 12
Edinburgh 11
Jacksonville 11
Los Angeles 10
Hebei 9
Seattle 9
Woodbridge 9
Atlanta 8
Hong Kong 8
Ann Arbor 7
Brno 7
Shenyang 7
Abidjan 6
Augusta 6
Houston 6
London 6
Auckland 5
Frankfurt am Main 5
Palermo 5
Berlin 4
Cambridge 4
Kish 4
Lancaster 4
Melbourne 4
Minsk 4
Toronto 4
Busan 3
Dallas 3
Guangzhou 3
Hangzhou 3
Izmir 3
Jiaxing 3
Jinan 3
Kunming 3
Leawood 3
Nanchang 3
Novato 3
Ottawa 3
San Diego 3
San Jose 3
Shanghai 3
São Paulo 3
Tianjin 3
Tokyo 3
Washington 3
Alatri 2
Almaty 2
Amsterdam 2
Budapest 2
Copenhagen 2
Esslingen am Neckar 2
Falkenstein 2
Ferentino 2
Genzano di Roma 2
Ghent 2
Guimarães 2
Gunzenhausen 2
Hounslow 2
Ivrea 2
Lanzhou 2
Lappeenranta 2
Lawrence 2
Manchester 2
Modigliana 2
Nuremberg 2
Paris 2
Portland 2
Priverno 2
Pune 2
San Francisco 2
Somerville 2
Totale 1.661
Nome #
Immune dyscrasia in adult growth hormone deficiency: Evaluation of hemolytic complement activity (CH50) and IgG subclasses 99
Evaluation of screening method for Bence Jones protein analysis 98
Solving the mystery of HBV-related mixed cryoglobulinemia: potential biomarkers of disease progression 94
Long-Lasting Rituximab-Induced Reduction of Specific—But Not Total—IgG4 in MuSK-Positive Myasthenia Gravis 83
Immunological role of IgG subclasses 83
Autoimmunity and lymphoproliferation markers in naïve HCV-RNA positive patients without clinical evidences of autoimmune/lymphoproliferative disorders 82
A novel biomarker score for the screening and management of patients with plasma cell proliferative disorders 79
Salivary biomarkers in covid-19 patients: Towards a wide-scale test for monitoring disease activity 78
Biomarkers of minimal residual disease in rituximab-treated patients with mixed cryoglobulinemia 76
Immunological role of IgG subclasses 75
The diagnostic performance of PIVKA-II in metabolic and viral hepatocellular carcinoma: A pilot study 74
Mono/polyclonal free light chains as challenging biomarkers for immunological abnormalities 71
The prognostic impact of monoclonal immune globulin and free light chain secretion in diffuse large B cell lymphoma (DLBCL) 70
Different biochemical patterns in type II and type III mixed cryoglobulinemia in HCV positive patients 68
Serological Immunoglobulin-Free Light Chain Profile in Myasthenia Gravis Patients 68
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 66
The Laboratory Role in anti-TNF Biological Therapy Era 65
Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma 65
Heavy chain disease: Our experience 63
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 63
Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu 62
Cryoglobulins: Identification, classification, and novel biomarkers of mysterious proteins 62
IgG cryoglobulinemia 60
Plasmatic free light chains as inflammatory marker in insulin resistance: comparison of metabolic syndrome with adult growth hormone deficiency 59
Cryoglobulins: putative effectors of adaptive immune response 59
Serum immunoglobulin free light chain levels in systemic autoimmune rheumatic diseases 58
Sentinel biomarkers in HCV positive patients with mixed cryoglobulinemia 58
Serum and urine free light chains measurements in patients with systemic sclerosis: novel biomarkers for disease activity 58
Free light chains a novel biomarker of cardiovascular disease. A pilot study. 57
Laboratory investigation of hybrid igg4 k/λ in musk positive myasthenia gravis 56
FREE LIGHT CHAINS: A NEW POTENTIAL BIOMARKER FOR DISEASE STRATIFICATION IN NON-ALCOHOLIC STEATOHEPATITIS 55
Lack of association between Vitamin D status and free light chains profile with different chronic HCV-related liver and extrahepatic disorders 54
Comparison of Fully Automated and Semiautomated Systems for Protein Immunofixation Electrophoresis 53
Serological profile of asymptomatic HCV positive patients with low level of cryoglobulins 52
Free light chains and autoimmunity 52
COVID-19, adaptative immune response and metabolic-associated liver disease 49
Serological and Molecular Characterization of Hepatitis C Virus-Related Cryoglobulinemic Vasculitis in Patients without Cryoprecipitate 38
Circulating histone signature of human lean metabolic-associated fatty liver disease (MAFLD) 38
Serum free light chain quantitative assays: Dilemma of a biomarker 36
Urinary lithogenic profile of patients with non-alcoholic fatty liver disease 33
Cytokines and Hepatocellular Carcinoma: Biomarkers of a Deadly Embrace 33
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 32
The dark side of current analytic methods for Bence Jones Proteinuria 31
Circulating and Salivary NGF and BDNF Levels in SARS-CoV-2 Infection: Potential Predictor Biomarkers of COVID-19 Disease-Preliminary Data 28
Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma 28
General Practitioner databaSe NAFLD (GPS-NAFLD) Study: preva-lence of advanced liver fibrosis among Italian primary care pa-tients with NAFLD 27
COVID-19 and hepatic involvement: The liver as a main actor of the pandemic novel 27
Multimorbidity and polypharmacotherapy in Italian primary care patients with NAFLD: General Practitioner databaSe NAFLD (GPS-NAFLD) Study 22
PREVALENCE OF ADVANCED LIVER FIBROSIS AMONG PRIMARY CARE PATIENTS WITH NAFLD. RESULTS FROM GENERAL PRACTITIONER DATABASE NAFLD (GPS-NAFLD) STUDY 20
NLRP3 Inflammasome Involvement in Heart, Liver, and Lung Diseases—A Lesson from Cytokine Storm Syndrome 14
Totale 2.831
Categoria #
all - tutte 15.180
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.180


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202086 0 0 0 0 3 15 21 1 2 16 27 1
2020/2021168 21 3 6 0 19 4 2 4 10 6 52 41
2021/2022396 11 2 5 69 30 16 11 62 20 16 65 89
2022/20231.139 177 145 74 168 68 121 72 89 121 17 63 24
2023/2024589 32 146 8 54 17 109 46 24 8 25 52 68
2024/2025317 53 37 85 46 96 0 0 0 0 0 0 0
Totale 2.831